GITS Global CEO highlights planned expansion into emerging markets as top strategic priority for the next two years Vertex Pharmaceuticals VRTX Robust Casgevy Early Launch Metrics Spark Counterintuitive Selloff for CoCommercialization Partner CRISPR Therapeutics DIBS 1stdibs shares fall 371 even as Q4 2025 EPS tops consensus analyst expectations SPDR SP 500 ETF Trust SPY BlueChip Wealth Advisors Full Exit of International Equity ETF Highlights US Allocation Trends The shareholder friendly policies at Stitch Fix SFIX Q1 2026 Earnings Beat Estimates What factors are influencing Boston Sci BSX stock Boston Sci posts 07 EPS beat versus analyst consensus estimates What Off The OTH does that keeps customers coming back Technical Weakness 20260506 Selective SIGIP Stock Entry Timing Analysis Q1 2026 Below Expectations